United States · FDA National Drug Code directory
SENNA-PLUS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57896-555_27ff1c70-104a-4f88-e063-6394a90a7e82
- Product NDC
- 57896-555
- Form
- TABLET
- Composition / generic term
- Sennosides and Docusate Sodium
- Labeler
- Geri-Care Pharmaceutical Corp
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20190501
- Source listing expiry
- 20261231
Source-listed ingredients
- SENNOSIDES — 8.6 mg/1
- DOCUSATE SODIUM — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (57896-555-01) · 57896-555-01
- 60 TABLET in 1 BOTTLE (57896-555-06) · 57896-555-06
- 1000 TABLET in 1 BOTTLE (57896-555-10) · 57896-555-10
- 200 TABLET in 1 BOTTLE (57896-555-20) · 57896-555-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →